NCT06185556View on ClinicalTrials.gov

COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

August 20, 2024

Primary Completion Date

September 1, 2029

Study Completion Date

September 1, 2031

Conditions
Colorectal CancerLiver MetastasesLiver Metastasis Colon CancerUnresectable Solid Tumor
Interventions
PROCEDURE

Irreversible electroporation

Percutaneous (CT-guided) irreversible electroporation of 1-3 perivascular and peribiliary colorectal liver metastasis.

RADIATION

Stereotactic body radiotherapy

Stereotactic body radiotherapy (CT- or MRI-guided) of 1-3 perivascular and peribiliary colorectal liver metastases.

Trial Locations (1)

1081 HV

RECRUITING

Amsterdam UMC - location VUmc, Amsterdam

Sponsors

Collaborators (1)

Angiodynamics, Inc.
All Listed Sponsors
collaborator

Angiodynamics, Inc.

INDUSTRY

lead

Amsterdam UMC, location VUmc

OTHER